OSIR
Osiris Therapeutics, Inc. Common Stock
OSIR
OSIR
Delisted
OSIR was delisted on the 16th of April, 2019.
64 hedge funds and large institutions have $117M invested in Osiris Therapeutics, Inc. Common Stock in 2013 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 17 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
48% less call options, than puts
Call options by funds: $2.64M | Put options by funds: $5.03M
Holders
64
Holding in Top 10
1
Calls
$2.64M
Puts
$5.03M
Top Buyers
| 1 | +$22M | |
| 2 | +$6.25M | |
| 3 | +$5.38M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$3.52M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$2.37M |
Top Sellers
| 1 | -$2.54M | |
| 2 | -$393K | |
| 3 | -$303K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$298K |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$222K |